Myomo Inc (MYO) - Kewajiban jangka dawa marang modal

Lambang korporat lan logo Myomo, Inc. (MYO)

Risks for Myomo, Inc. (MYO) are linked to a dependence on insurance reimbursements for MyoPro; however, the share of long-term loans to equity on the general GURU.Markets platform chart, where 2.99 represents the latest metric reading, confirms stability. Myomo, Inc. (MYO)'s status as a leader in myoelectrics and the trust of physicians mitigate volatility, while product uniqueness and government program approvals ensure high margins and increased efficiency.

Utang jangka dawa marang modal: Myomo, Inc (MYO) kanggo 04.07.2022 - 30.10.2026
Barang utama myomo.com

This indicator determines the share of long-term liabilities within the equity structure, measuring financial leverage and default risk in the event of declining revenues. By analyzing the long-term debt-to-equity ratio, an investor assesses the business's ability to service loans with maturities exceeding one year. For Myomo, Inc. (MYO), this metric is critical, as demand for exoskeletons remains stable and independent of market cycles. Insurance coverage of patient expenses minimizes the risk of insolvency. Low revenue volatility renders the debt load predictable and sustainable.

Perusahaan pesaing

Boston Scientific Corp - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal EW|RMD - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal PODD (Insulet Corporation)|ZBH - Rasio utang jangka dawa marang ekuitas|CooperCompanies - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal Invisalign ALGN|GMED: Utang jangka dawa marang modal|TransMedics Group, Inc. (TMDX) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Alphatec Holdings, Inc.|Utang jangka dawa marang ekuitas AORT|Utang jangka dawa marang modal ENOV|Rasio tanggungan utang jangka dawa marang modal Integra LifeSciences Corp|Motiva - Rasio utang jangka dawa marang ekuitas|BBNX (iLet Bionic Pancreas) - Kewajiban jangka dawa marang ekuitas|IRADIMED CORPORATION - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal embecta.com|TNDM: Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal AXGN|Rasio utang jangka dawa marang ekuitas SIBN|OFIX: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Bioventus Inc. (BVS)|Rasio utang jangka dawa marang ekuitas orthopediatrics.com KIDS|Utang jangka dawa marang modal TMCI (Treace Medical Concepts, Inc.)|Blade Air Mobility (SRTA) - Kewajiban jangka dawa marang modal|Carlsmed Corp - Utang jangka dawa marang modal|RXST (RxSight Ophthalmic) - Rasio utang jangka dawa marang modal|CLPT: Utang jangka dawa marang modal|STXS - Rasio tanggungan utang jangka dawa marang modal|STIM (Neuronetics) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Sight Sciences Inc. (SGHT)|Utang jangka dawa marang modal OBIO|Utang jangka dawa marang modal anikatherapeutics.com (ANIK)|Utang jangka dawa marang ekuitas InspireMD, Inc. NSPR|Jin Medical International Ltd. - Utang jangka dawa marang ekuitas|VANI: Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal XTNT (Xtant Medical Holdings)|NMTC: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Modular Medical, Inc. (MODD)|Utang jangka dawa marang ekuitas Envoy Medical, Inc.|VVOS - Tanggungan utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas NVNO (enVVeno Medical Corp.)|Utang jangka dawa marang modal sintx.com (SINT)|Utang jangka dawa marang modal TNON (Tenon Medical, Inc)|Rasio tanggungan utang jangka dawa marang modal Lifeward Ltd. (LFWD)|AMIX - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas IVF|Bone Biologics Corp (BBLG) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Axonics Inc.|BIOL (Biolase, Inc.) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Dynatronics Corp. DYNT|Utang jangka dawa marang ekuitas Paragon 28, Inc. (FNA)|invobioscience.com - Rasio utang jangka dawa marang modal